Fengmin Lu
Impact in
- Hepatology top 0.5%
- Hepatitis C virus research
- Hepatitis Viruses Studies and Epidemiology
- Epidemiology top 1%
- Hepatitis B Virus Studies
- Liver Disease Diagnosis and Treatment
Papers in
- Epidemiology 110
- Hepatitis B Virus Studies 89
- Liver Disease Diagnosis and Treatment 52
- Hepatology 65
- Hepatitis C virus research 45
- Hepatitis Viruses Studies and Epidemiology 13
- Liver Disease and Transplantation 8
- Co-authors
- Xiangmei Chen (91 shared papers)Hui Zhuang (31 shared papers)Jun Nie (6 shared papers)Dongzhi Yang (5 shared papers)J. Alan Diehl (3 shared papers)Qiang Xu (3 shared papers)Yingshan Zhou (2 shared papers)Andrew B. Gladden (1 shared paper)
- Journals
- Journal of Medical Virology (10 papers)Emerging Microbes & Infections (9 papers)Journal of Viral Hepatitis (7 papers)PLoS ONE (7 papers)Oncotarget (7 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Fengmin Lu
222 papers receiving 6.1k citations
Peers
Comparison fields: 5 of 138
- Hepatology 1.2k
- Epidemiology 1.7k
- Cancer Research 656
- Biomaterials 546
- Oncology 791
Countries citing papers authored by Fengmin Lu
This map shows the geographic impact of Fengmin Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengmin Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengmin Lu more than expected).
Fields of papers citing papers by Fengmin Lu
This network shows the impact of papers produced by Fengmin Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengmin Lu. The network helps show where Fengmin Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Fengmin Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 234 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 422 | |
| 2 | An alternatively spliced cyclin D1 isoform, cyclin D1b, is a nuclear oncogene. | 2003 | 206 |
| 3 | 2017 | 205 | |
| 4 | 2013 | 137 | |
| 5 | 2008 | 124 | |
| 6 | 2020 | 123 | |
| 7 | 2013 | 120 | |
| 8 | 2010 | 118 | |
| 9 | 2006 | 114 | |
| 10 | 2011 | 110 | |
| 11 | 2012 | 97 | |
| 12 | 2013 | 93 | |
| 13 | 2019 | 87 | |
| 14 | 2008 | 84 | |
| 15 | 2012 | 81 | |
| 16 | 2010 | 80 | |
| 17 | 2020 | 76 | |
| 18 | 2008 | 75 | |
| 19 | 2007 | 71 | |
| 20 | 2018 | 68 |
About Fengmin Lu
Fengmin Lu is a scholar working on Epidemiology, Hepatology, Molecular Biology, Oncology and Immunology, having authored 234 papers that have together received 6.2k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (89 papers), Liver Disease Diagnosis and Treatment (52 papers), Hepatitis C virus research (45 papers), Hepatitis Viruses Studies and Epidemiology (13 papers), Epigenetics and DNA Methylation (10 papers), Cancer-related Molecular Pathways (10 papers), RNA modifications and cancer (9 papers) and Liver Disease and Transplantation (8 papers). The work is most often cited by research in Hepatology (1.2k citations), Epidemiology (1.7k citations), Cancer Research (656 citations), Biomaterials (546 citations) and Oncology (791 citations). Fengmin Lu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Xiangmei Chen, Hui Zhuang, Jun Nie, Dongzhi Yang, J. Alan Diehl, Qiang Xu, Yingshan Zhou, Andrew B. Gladden, Jie Wang and Mingjie Yao. Their work appears in journals such as Journal of Medical Virology, Emerging Microbes & Infections, Journal of Viral Hepatitis, PLoS ONE and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.